STUART SILVERMAN
BEVERLY HILLS, CA NPI 1679670822
Browse related groups: CA Sandoz Inc. All categories
General Payments — all program years on this page
$375,546.11
- Category: General Payments
- Program years: PY2018–2024
- Record count: 1,318
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $10,704.56 across 118 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $7,700.00 | 1 |
| Food and Beverage | $2,959.56 | 116 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $45.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Sandoz Inc. | $7,700.00 | 1 |
| Amgen Inc. | $667.82 | 29 |
| ABBVIE INC. | $504.20 | 19 |
| Radius Health, Inc. | $415.54 | 19 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $326.57 | 11 |
| Alvogen Inc | $222.35 | 8 |
| PFIZER INC. | $142.62 | 5 |
| UCB, Inc. | $120.00 | 1 |
| Janssen Biotech, Inc. | $104.82 | 4 |
| Mallinckrodt Hospital Products Inc. | $88.93 | 3 |
| Acerta Pharma LLC | $81.22 | 4 |
| GlaxoSmithKline, LLC. | $74.46 | 4 |
| Aurinia Pharma U.S., Inc. | $42.27 | 2 |
| Dompe US, Inc. | $36.56 | 1 |
| Lilly USA, LLC | $32.06 | 1 |
| SHIELD THERAPEUTICS INC | $30.05 | 1 |
| Phathom Pharmaceuticals, Inc. | $28.98 | 1 |
| Kiniksa Pharmaceuticals International, plc | $25.50 | 1 |
| Octapharma USA, Inc. | $24.75 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.81 | 1 |
| Azurity Pharmaceuticals, Inc. | $16.05 | 1 |
By program year
Records — PY2024 (118)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.